Anlon Healthcare Ltd - 544497 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
Anlon Healthcare executed Share Swap Agreements to acquire up to 32.52% in Apiqo Organics Private Limited and up to 43.33% in Bizotic Lifescience Private Limited. These strategic acquisitions, totaling approximately Rs. 153.29 crore through preferential share issuance, aim to strengthen the company's supply chain and achieve synergies in the pharmaceutical sector.
Aug 08 2026 18:00:45
Anlon Healthcare Ltd - 544497 - Board Meeting Intimation for Approve Notice Of 13Th Annual General Meeting Of The Company
Anlon Healthcare's board will convene on August 11, 2026, to consider and approve its audited financial results for the financial year ended March 31, 2026. The agenda also includes approving a preferential issue of equity shares in lieu of an acquisition.
Aug 06 2026 20:59:46
Anlon Healthcare Ltd - 544497 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Anlon Healthcare has scheduled an earnings conference call on August 06, 2026, at 4:00 PM (IST) to discuss its audited financial results for Q1 FY27 (quarter ended June 30, 2026). The call will feature Managing Director Mr. Punit Rasadia and will be based on publicly available information.
Jul 31 2026 12:56:47
Anlon Healthcare Ltd - 544497 - Board Meeting Intimation for Declaration Of Financial Results For The Quarter Ended June 30, 2026
Anlon Healthcare's Board of Directors will meet on July 30, 2026. The agenda includes considering the acquisition of 32.52% shareholding in Apiqo Organics Private Limited and 43.33% in Bizotic LifeScience Private Limited via a share swap arrangement, aiming to make them wholly-owned subsidiaries. The board will also review Q1 FY27 financial results.
Jul 27 2026 20:45:57
Anlon Healthcare Ltd - 544497 - Announcement For Incorporation Of Subsidiary Company
Anlon Healthcare has incorporated Anlon Biologics Private Limited as a new 65% owned subsidiary. This strategic move aims to expand the company's business into the manufacturing of surgical implants and medical devices, leveraging opportunities in the growing healthcare segment.
Jul 11 2026 16:17:10
Read More